The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ciltacabtagene autoleucel: The second anti-BCMA CAR T-cell therapeutic armamentarium of relapsed or refractory multiple myeloma
|
|---|---|
| Published in |
Frontiers in immunology, September 2022
|
| DOI | 10.3389/fimmu.2022.991092 |
| Pubmed ID | |
| Authors |
Endeshaw Chekol Abebe, Mestet Yibeltal Shiferaw, Fitalew Tadele Admasu, Tadesse Asmamaw Dejenie |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 95 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 10 | 11% |
| Student > Ph. D. Student | 8 | 8% |
| Researcher | 7 | 7% |
| Student > Master | 6 | 6% |
| Unspecified | 5 | 5% |
| Other | 9 | 9% |
| Unknown | 50 | 53% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 15 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 8% |
| Medicine and Dentistry | 6 | 6% |
| Unspecified | 5 | 5% |
| Immunology and Microbiology | 4 | 4% |
| Other | 3 | 3% |
| Unknown | 54 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2023.
All research outputs
#7,640,347
of 26,170,906 outputs
Outputs from Frontiers in immunology
#8,974
of 33,018 outputs
Outputs of similar age
#136,879
of 436,159 outputs
Outputs of similar age from Frontiers in immunology
#446
of 2,047 outputs
Altmetric has tracked 26,170,906 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 33,018 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,159 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 2,047 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.